Jacobi Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,000
Closed -$96K 988
2021
Q3
$96K Hold
2,000
0.01% 525
2021
Q2
$90K Hold
2,000
0.01% 511
2021
Q1
$96K Hold
2,000
0.01% 460
2020
Q4
$108K Hold
2,000
0.02% 399
2020
Q3
$74K Hold
2,000
0.01% 428
2020
Q2
$62K Hold
2,000
0.01% 443
2020
Q1
$55K Hold
2,000
0.01% 408
2019
Q4
$59K Hold
2,000
0.01% 439
2019
Q3
$38K Hold
2,000
0.01% 491
2019
Q2
$44K Hold
2,000
0.01% 473
2019
Q1
$41K Hold
2,000
0.01% 445
2018
Q4
$25K Hold
2,000
0.01% 493
2018
Q3
$31K Hold
2,000
0.01% 502
2018
Q2
$26K Hold
2,000
0.01% 530
2018
Q1
$16K Hold
2,000
﹤0.01% 610
2017
Q4
$17K Hold
2,000
0.01% 576
2017
Q3
$22K Hold
2,000
0.01% 487
2017
Q2
$18K Hold
2,000
0.01% 472
2017
Q1
$15K Hold
2,000
0.01% 412
2016
Q4
$17K Hold
2,000
0.01% 353
2016
Q3
$16K Hold
2,000
0.01% 403
2016
Q2
$16K Buy
+2,000
New +$16K 0.01% 383

Other funds holding NEO

Jacobi Capital Management's NEO Position: Q4 2021 in Review

Jacobi Capital Management sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 2,000 shares — an estimated $96K sold.

Jacobi Capital Management first reported a position in NEO in Q2 2016 and held it in 22 quarters. The position peaked at $108K in Q4 2020. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Jacobi Capital Management reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 2,000 NeoGenomics shares in Q4 2021, an estimated $96K.
  • Jacobi Capital Management first reported a position in NeoGenomics in Q2 2016 and held it in 22 quarters.
  • Jacobi Capital Management's NeoGenomics position peaked at $108K in Q4 2020.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.